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Ojochenemi J Onubi, Amudha S Poobalan*, Brendan Dineen, Debbi Marais and Geraldine McNeillAbstract
Background: Child undernutrition has short and long term consequence for both individuals and society. Previous
studies show probiotics may promote child growth and have an impact on under-nutrition.
Methods: A systematic review of the literature was carried out on three electronic databases to assess evidence.
The outcome measured was change in weight or height. A narrative analysis was conducted due to heterogeneity
of included studies.
Results: Twelve studies were included in the review of which ten were randomised controlled trials. A total of 2757
children were included, with 1598 from developing countries. The studies varied in type and quantity of probiotics
given, duration of interventions, characteristics of participants, setting and units of outcome measures. Overall, five
studies found a positive effect of probiotics on child growth. All five were conducted in developing countries with
four studies conducted in mostly under-nourished children and one in well-nourished children. No significant effect
on growth was found in the seven studies that were conducted in developed countries.
Conclusion: The limited evidence suggests that probiotics have the potential to improve child growth in
developing countries and in under-nourished children. More research is needed to explore this further.
Keywords: Probiotics, Child growth, Systematic reviewBackground
In 2011, the World Health Organisation (WHO) esti-
mated that globally, 115 million (18%) children under-
five years of age were underweight and 178 million
(28%) were stunted [1]. A quarter of all children in de-
veloping countries suffer from malnutrition [2] with the
majority of them residing in Africa and Asia [1]. Under-
nutrition in children under five years of age increases
the risk of mortality and morbidity due to diarrhoea and
increased risk of infections by an estimated 35% and
11% respectively [3]. It also leads to long-term conse-
quences such as delay of educational, social and eco-
nomic development [4]. There has been some progress
in the reduction in the proportion of underweight chil-
dren under five years of age in developing countries
from 30% to 23% between 1990 and 2009 [5], however,
not sufficient to meet the Millennium Development* Correspondence: a.poobalan@abdn.ac.uk
Public Health Nutrition Group, Institute of Applied Health Sciences, University
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unless otherwise stated.Goal to reduce the under-five mortality rate by two
thirds by the year 2015 [5].
Infectious disease (particularly diarrhoeal disease) is one
of the underlying causes of under-nutrition (both macro
and micronutrient deficiencies) through different mecha-
nisms [3]. These nutrients are essential for adequate child
growth and development and continuous poor nutrition
results in poor growth [3,4]. Child growth has been identi-
fied as an important indicator for measuring the nutri-
tional status and health of populations [6].
The past decade has seen a new era in medical science
with increased use of ‘probiotics’ for health benefits,
especially in diarrhoeal diseases. Probiotics are defined
as live organisms which have health benefits for the host
if taken in adequate amounts [7]. There have been re-
cent reviews published on the effects of probiotics in
children with specific disease conditions such as acute
infectious diarrhoea [8], antibiotic-associated diarrhoea
[9], necrotizing enterocolitis in very low birth weight in-
fants [10], childhood atopy, Helictobacter pylori infection
and infantile colic [11].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tions such as infectious diarrhoea [8,12,13] as well as the
incidence and duration of upper respiratory tract infec-
tions [12,14]. Probiotics may improve child growth
through the prevention of infections and micronutrient
deficiencies as they have been shown to improve the ab-
sorption of certain nutrients (calcium, zinc and vitamin
B12) [12,15] and reduce the risk of anaemia [16].
Probiotics have been ingested for centuries, as part of
fermented food products [7] and they have been isolated
from traditional fermented products such as fermented
milk ‘wara’ in Nigeria [17] and ‘Kule naoto’ among the
Maasai in Kenya [18]. Fermentation is widely practiced
and accepted in many regions of the world, particularly
in Africa and Asia where fermented foods form a signifi-
cant portion of the diets of rural communities [19]. In
many African countries, the fermentation process is used
to prepare complementary foods and therefore fermen-
ted foods are important in infant and child nutrition
[20]. The process of fermentation is economical [19] and
the potential use of fermented food to improve infant
and young child feeding was explored during a joint
Food and Agriculture Organization (FAO) and WHO
workshop held in 1995 [21].
Consequently, the use of locally grown/culturally
acceptable probiotic products could be used to improve
the growth of the children at a low cost and could be
implemented at large scale to reach the target commu-
nity [22]. In spite of this recognition, only two systematic
reviews to date have investigated the effects of probiotics
on weight gain [23,24]. Both reviews however, focused
on specific probiotic strains in target populations i.e. the
review by Steenhout et al. in 2009 assessed the effects of
bifidobacterium lactis in children younger than six
months [24] and Million et al. assessed effects of lacto-
bacillus species on weight gain in animals and healthy
humans [23]. The aim of this review is to add to the evi-
dence of the effects of probiotics on child growth irre-
spective of age, type of probiotic bacteria or nutritional
status of the children.
Methods
Three electronic bibliographic databases (Medline, Embase
and Cochrane Library) were systematically searched using
a robust search strategy. Literature published between
1947 and July 2011 was searched with no language restric-
tions. The Medline strategy (Additional file 1) was modi-
fied for the other databases. The Medline and Embase
searches were updated using the same search strategy on
the 26th October 2012 to identify any recent studies. All
study designs that looked at use of any probiotic product
in well-nourished and under-nourished children were
included in the review. MeSH (Medical Subject Headings)
terms and text words for ‘probiotics’, and ‘fermented milkproduct’ were combined appropriately with terms for
‘growth’, ‘anthropometry’ and ‘children’ to identify relevant
studies. Studies that looked at probiotic use for the man-
agement of a disease condition; in children who had a
specific disease condition rather than the management of
under-nutrition and those that targeted other population
groups such as pregnant women and children with
impaired growth at birth were excluded.
Abstracts were read by two independent reviewers
(OO and AP) to identify relevant studies. Full text arti-
cles of potentially eligible studies that met the selection
criteria were obtained. Initially, the papers were critically
appraised by two independent reviewers (OO and AP)
until high consistency between the reviewers was
achieved, and thereafter by one reviewer (OO). Refer-
ence lists of all included studies and review articles iden-
tified by the search were also checked to identify other
relevant studies. One French language paper was profes-
sionally translated to English. All studies were assessed
for methodological quality using a modified Cochrane
review quality assessment form [25]. The reviewers were
not blinded to the authors, journals, country of publica-
tions, results and conclusions of the papers.
A data extraction form was designed using guidelines
from the University of York Centre for Reviews and
Dissemination (CRD) checklist, piloted and amended be-
fore being used by two independent reviewers (OO and
AP) to extract the data from the papers [26]. As available
data in the published papers was sufficient for the
narrative analysis that was conducted in this review,
authors of primary studies were not contacted for any
further information. Reviewers consulted regularly with
each other to discuss any inclusion queries as they
arose. Outcome measures assessed were change in
weight, length/height, head circumference, Body Mass
Index (BMI) and mortality rate. A narrative synthesis
was conducted as meta-analysis of the data could not
be undertaken due to heterogeneity of the studies in
terms of different probiotic preperations used, age
range of the participants, the timing of measurement of
outcome variables and the growth measurement units
(g/day, z-scores) between studies.
Ethical clearance
Ethical clearance was not required as this is a systematic
review of literature, and anonymized data was used.
Results of the literature search
The initial systematic search identified 1056 citations, of
which 49 potentially eligible articles were critically ap-
praised. Ten studies met the inclusion criteria (Figure 1 –
Prisma statement). The update search identified two
recent relevant articles [27,28] giving a total of twelve
studies to be included in this review.
Figure 1 Flow chart of the systematic review results.
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(RCTs) [12,16,27-34] and two were non-randomised clin-
ical controlled trials [13,35]. Five of the studies were con-
ducted in developing countries in Asia [12,13,16,28,29].
The basic characteristics of the included studies are
presented in Table 1. For this review we defined the
study populations as ‘well-nourished’ if the anthropo-
metric measurements showed that the majority of
children were not stunted or wasted, and/or if the au-
thors presented them as ‘healthy’; and as ‘under-nour-
ished’ if the majority of children were underweight,
stunted or wasted or if the authors presented them as
‘unhealthy’. Eight of the studies were conducted inwell-nourished children [27,29-35] while four were con-
ducted in under-nourished children [12,13,16,28]. All the
studies in under-nourished children were conducted in
developing countries while those on well-nourished chil-
dren were conducted in developed countries except one
study from Indonesia [29]. The age of the participants
ranged from less than 28 days [30,31,33-35], to between
one month and five years [12,13,16,27-29,32].
Probiotics were used in different combinations i.e. as a
single probiotic [13,16,27,28,30,31,33-35] or multiple
probiotics [12,29,32]; alone [12,13,27,28,32-35] or in
combination with other products such as prebiotics
[16,31] and long chain polyunsaturated fatty acids (LC-
Table 1 Basic characteristics of studies
Citation Country Sample
size(n)
Age/Gender:
M/F
Description of intervention
(I) and control (C) groups
Duration of intervention
and Follow up
Outcome measures
Healthy children
Firmansyah
et al. 2009
[29] Indonesia
n = 393 12 months I: Bifdobacterium longum and
Lactobacillus rhamnosusin
Duration:12 months Weight gain per day and
change in length measured
between 12 months and
16 months
I: 199 Gender: both
(M/F):
200 ml Milk twice daily + prebiotics
and LC-PUFA + Normal Diet
No Follow up Other unrelated outcomes
(motor and behavioural
functions were measured at
the end of the intervention)C: 194 I = 101/98 C: 200 ml Milk twice daily +
Normal Diet with no probiotics
Measurements
for weight gain
taken after 4 months
(16 months of age)
C = 102/92
Scalabrin et al.
2009 [33] USA
n = 286 14 days I: Lactobacillus rhamnosus in Duration: from 14–120
days of age
Weight growth rate between
14 and 120 days of age
I(a): 94 Gender: both (a): Extensively hydrolyzed formula
(EHF)
No follow-up Length
I(b): 98 (M/F): (b): Partially hydrolyzed formula
(PHF)
Head circumference
C: 94 I(a): 50/44 C: EHF without probiotic (Length and head circumference
measures were obtained at 30,
60, 90, 120, and 150 days of age)I(b): 49/49 All children were exclusively
formula fed and on demand
C: 44/50
Saavedra et al.
2004 [32] USA
n = 131 3–24 months I (High supplement (HS)): 1 x 107
Bifdobacterium lactis Bb12 and
streptococcus thermophilus CFU/g
of standard milk based formula
Mean duration:
210 ± 127 days
Monthly weight and length
I(HS): 44 Gender: both
(M/F):
I (Low supplement(LS)): 1 x 106
Bifdobacterium lactis Bb12 and
streptococcus thermophilus CFU/g
of standard milk based formula
No follow-up
I(LS): 43 I(HS): 22/17 C: Standard milk based formula
with no probiotics
C: 44 I(LS): 21/19 Intake in each group had to be≥
240 ml/day for more than 14 days
C: 16/24
Gibson et al.
2009 [30] Australia
n = 142 0–10 days I: Bifdobacterium lactis 3 · 85 x 108
CFU+
Duration: 7 months Weight gain per day,
recumbent length, head
circumference for 7 months,
weight gain (g/d) from day
14 to day 119 (period of
exclusively feeding the test
formulas)
I: 72 Gender: both LC-PUFA(DHA) and AA in infant
formula
No Follow up
C: 70 Intervention
Female: 56%
C: infant formula Others were BMI, and
occurrence of adverse events
Control (Measurements conducted at
approx. 2, 4, 6, 13, 17, 26,
30 weeks of age)Female: 53% All children were exclusively formula
fed but were allowed weaning from
4 months during which at least
500 ml/day of formula to be
consumed
Ziegler et al. 2003
[34] USA
n = 122 6–10 days I(RP + P): Bifdobacterium lactis in
reduced protein formula (RP)
Duration: Fed till
112 days of age
(approximately 4
months of age)
Weight and length gain per day
between 8-56 days, 56–112 days
and 8–112 days
I(RP + P): 40 Gender: both
M/F ratio
I(RP): Reduced protein formula
I(RP): 40 Not reported C: Normal protein formula No Follow up
C: 42
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Table 1 Basic characteristics of studies (Continued)
Puccio et al. 2007
[31] Italy
n = 138 Full term
infants
(<14 days)
I: 2 x 107 Bifdobacterium longum
BL999 + 4 g/litre prebiotic in Infant
formula
Duration: 7 months Mean weight gain,
recumbent length, head
circumference at 14, 28,
56, 84 and 112 days of age
I: 42 Gender M/F: C: Formula without probiotics No Follow up
C: 55 I: 20/22
C: 25/30
Huet et al. 2006
[35] France
n = 203 1 – 28 days I: Bifdobacterium lactis infant
formula
Duration: 90 days Daily weight gain, daily
increase in height from
day 0 to day 90
I: 117 Gender: both
M/F ratio not
reported
C: Infant formula No follow up
C: 86
Gil-Campos et al.
2011 [27] Spain
N = 137 One month old
infants
I: 107 cfu/g Lactobacillus fermentum
CECT5716 + galactooligosaccharides
(0.3 g/100 ml) in infant formula
Duration: 5 months Average daily weight
gain between baseline
(one month) and 4
months of age
I: 66 Gender M/F: C: galactooligosaccharides
(0.3 g/100 ml) in infant formula
No follow up
C: 71 I: 34/27
C: 38/22
Undernourished children
Sazawal et al.
2010 [16] India
n = 624 1–3 years I: 1.9 x 107 CFU per day of
Bifdobacterium lactis
HN019 + 2.4 g/day prebiotic
in milk powder
Duration: One year Weight gain at 6 months
and 1 year
I: 312 Gender: both
M/F ratio not
reported
C: milk powder No follow-up
C: 312
Saran et al. 2002
[13] India
n = 100 2–5 years I: Lactobacillus acidophilus in
curd (beet juice added) 1 x 108
organisms/gm
Duration: 6 months Body weight, height for
6 months
I: 50 Gender: both C: Isocaloric supplement (biscuits) No follow up Incidence of morbidity
with respect to diarrhoea-
frequency, severity and
duration
C: 50 Equal numbers
He et al. 2005 [12]
China
n = 402 3–5 years I: Thermophilus streptococci,
Bulgaria lactobacilli and bifidum
bacteria in yogurt
Duration: 9 months Body weight, height at 3,6
and 9 months
I: 201 Gender: both + normal diet No follow up
C: 201 M/F: C: Normal Diet
I: 106/95
C: 111/90
Surono et al. 2011
[28] Indonesia
n = 79 15-54 months I: 1 mg lyophilized Enterococcus
faecium IS-27526 (2.31 x 108 cfu/day)
in 125 ml commercial UHT low fat milk
Duration: 90 days Body weight
I: 39 Gender: both No follow up
C: 40 M/F: C: 1 mg maltodextrin in 125 ml
commercial UHT low fat milk
I: 17/22
C: 17/23
NCHS: National centre for health statistics.
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of the studies [16,27-35] compared a probiotic enriched
formula/food/milk in the intervention group with a con-
trol group who had the same products but no probiotic
added to it. One study compared probiotic food with nointervention (i.e. just a normal diet) in the other group
[12] and another study compared probiotic enriched
yoghurt with biscuits of the same caloric value [13].
The duration of supplementation with probiotics and
timing of anthropometric measurements also varied across
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studies in this review investigated the effects of probiotics
on growth in children. However, five of them measured
the ‘difference in growth’ as their primary outcome by
comparing children who were fed with probiotics with
those who were not [12,13,16,28,29]. The seven other
studies [27,30-35] measured the ‘safety and tolerance’ of
probiotics in infant formula as their primary outcomes
while measuring ‘growth’ as a secondary outcome.
Results of the review
Well-nourished children
Out of eight studies that were conducted among well-
nourished children, only one study conducted in
Indonesia, showed a significant difference in weight gain
(0.93 g/day; p = 0.025) and weight-for-age (p = 0.036) be-
tween the intervention and control groups [29]. This
was significantly higher than the growth standards rec-
ommended by the WHO [36] for that age group. The
intervention group were given probiotics in addition to
prebiotics and LC-PUFA and compared with a control
group following a normal diet for a four month study
period (Table 2, Section 1). Two major differences be-
tween this Indonesian study which showed improved
weight gain and the other studies, are the settings of the
studies and the age range of the participants. The chil-
dren in the Indonesian study were older (aged 12
months and older) than the children in the other seven
studies who were either less than 28 days of age
[30,31,33-35], one month [27], or seven months of age
[32]. With regards to the difference in settings, the study
was conducted in a developing country (Indonesia) while
the other seven studies were conducted in developed
countries [27,30-35]. No significant improvements were
seen in any of the other growth outcomes measured by
height, head circumference or BMI.
Under-nourished children
Four studies were conducted among under-nourished
children between the ages of one and five years
[12,13,16,28]. All four studies were conducted in devel-
oping countries. In two of these studies, all the children
were under-nourished [12,13], while in the remaining
two studies there was a mixture of children who were
normal weight, underweight, stunted and/or wasted
(Table 2, Section 2) [16,28]. All four studies found im-
proved weight in the probiotic group compared with the
control group. Three studies showed increased weight
gain in grams after six (1290 ± 730 vs 810 ± 840) [13],
nine (1420 ± 760 vs 1200 ± 670) [12], and 12 (2130 ± 590
vs 2000 ± 590) [16] months of supplementation in the
probiotic groups compared with the control groups re-
spectively. However, the mean differences were not re-
ported in any of the studies. He et al. [12] also notedsignificant increases in change in weight-for-age z-
scores. In the fourth study by Surono et al. [28], the
mean weight gain of mostly under-nourished children in
the probiotic group was 1280 ± 940g compared with the
children in the control group with mean weight gain of
990 ± 990 g. This difference became significant when the
results were stratified by nutritional status (normal
weight, underweight and severly underweight) as chil-
dren with normal body weight in the probiotic group
weighed significantly more than those in the control
group. Regarding the other growth outcomes, two stud-
ies found a significant difference in height of the chil-
dren [12,13]. In He et al. [12], the children in the
probiotic group had a change in height-for-age z-score
of 0.123 ± 0.168 while those in the control group had a
change in height-for-age z-score of 0.077 ± 0.175 at nine
months of supplementation (p < 0.01). Again, this in-
crease in height-for-age z-scores in the probiotic group
was significantly higher than the reference value recom-
mended by the WHO for children of that age group
while in the control group, the change was less than the
WHO reference value [36]. The other study by Saran
et al. [13] showed that, after 6 months, the children in
the probiotic group grew an average of 3.21 ± 1.48 centi-
metres in length compared to the control group 1.74 ±
0.80cm (p = 0.0001).
Discussion
This review found a benefit of dietary intake of probio-
tics in weight and length/height gain, potentially in chil-
dren who are under-nourished and also healthy children
living in developing countries. In clinics worldwide, the
WHO growth charts are used for monitoring the growth
of children in relation to that of the expected value for
age [36]. Two out of the five studies [12,29] that showed
significant improvement in growth, noted that the chil-
dren in the probiotic groups had growth curves that
were significantly higher than [12] or closer to [29] the
WHO reference value than the children in the control
groups. One other notable finding in one study [12] is
the improvement in height-for-age z-scores in children
who took probiotics compared to those in the control
group. Change in height-for-age z-scores indicates
catch-up growth in children [37], therefore, probiotics
may help in promoting compensatory growth of children
with stunted growth [3]. The effect of probiotics on the
growth of under-nourished children was also investi-
gated in a large RCT (PRONUT study) by Kerac et al.
[38]. In this study, probiotics did not seem to confer any
benefits on the health or the nutritional status of these
children. However, compared to the other studies con-
ducted in undernourished children in this review who
were community living and suffered from chronic un-
dernutrition, the children in the PRONUT study were
Table 2 Effects of probiotics on child growth
Section 1: In healthy children
Author, year Sample details Outcomes and units of
measurement
Results
Country
Type of study
Quality
Firmansyah et al. 2009 [29] Intervention: Outcome: Outcome Intervention Control Mean difference (CI) p-value
Indonesia Age: 12 months Weight, Length, Head
circumference,
Body Mass Index (BMI)
Sample size 161 153
RCT Sample size: 199 Weight (g/day) 7.57 ± 4.13 6.64 ± 4.08 0.93 (0.12-1.95) 0.025
Quality: Control: Units of measurement: Change in weight-for-age 0.11 ± 0.40 0.02 ± 0.40 0.09 (0.01-0.18) 0.036
Unclear risk of bias for
allocation concealment
Age: 12 months Weight: Weight (g) 9711 ± 1142 9643 ± 1218 Not reported Not reported
Sample size: 194 Weight gain (g/day) Length (cm) 77.8 ± 3.0 77.9 ± 3.4 Not reported Not significant
Change in weight-for-age
after 4 months
Head circumference (cm) 46.3 ± 1.3 46.4 ± 1.4 Not reported Not significant
Weight (g) BMI (kg/m2) 16.0 15.9 Not reported Not reported
Length: Length after
4 months (cm)
Head circumference: Head
circumference after
4 months (cm)
BMI: kg/m2
Scalabrin et al. 2009 [33] Intervention: Outcome: Outcome Intervention
1- EHF + P
Intervention
2 - PHF + P
Control EHF Mean difference p-value
USA Age: 14 days Weight, Length, Head Sample size 63 77 70
RCT Sample size: circumference Weight gain (g/day) 28.4 ± 0.67 26.8 ± 0.76 27.6 ± 0.72 Not reported Not
Significant
Quality: -Extensively hydrolysed
formula with probiotic
(EHF + P): 94
Units of measurement: Length (cm/day) 0.11 ± 0.002 0.11 ± 0.002 0.11 ± 0.002 No difference
Low risk of bias for all
parameters
-Partially hydrolysed
formula with probiotic
(PHF + P): 98
Weight: Head circumference (cm/day) 0.05 ± 0.001 0.05 ± 0.001 0.05 ± 0.001 No difference
Weight gain (g/day) ANOVA, 1-tailed t-tests
Control: Length: change in length
(cm/day)
Age: 14 days
Sample size: Extensively
hydrolysed formula
without probiotic
(EHF): 94
Head circumference:
Change in head
circumference (cm/day)
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Table 2 Effects of probiotics on child growth (Continued)
Saavedra et al. 2004 [32] Intervention: Outcome: Outcome Intervention 1
(HS)
Intervention 2
(LS)
Control Mean difference p-value
USA Age: 3–24 months Weight and Height Sample size 39 39 40
RCT Sample size: Units of measurement: Change in
weight-for-age
0.09 ± 0.64 0.06 ± 0.72 0.16 ± 0.69 Not reported Not
significant
Quality: -High Supplement
probiotic in formula
(HS): 39
Weight: Change in
weigh-for-length
0.40 ± 0.85 0.53 ± 1.10 0.45 ± 0.75 Not reported Not
significant
Unclear risk of bias in
allocation concealment
-Low Supplement
probiotic in formula
(LS): 39
change in weight-for-age
z-score
Change in
height-for-age
−0.06 ± 0.44 −0.09 ± 0.60 −0.04 ± 0.59 Not reported Not
significant
Control- formula change in weight-for-length
score
Age: 3–24 months Height:
Sample size: 40 change in height- for-age
z-score
Gibson et al. 2009 [30] Intervention: Outcome: Outcome Intervention Control Mean difference p-value
Australia Age: <10 days Weight, Length, Head
Circumference, BMI
Sample size: 62 62
RCT Sample size: 72 Units of measurement: Weight gain (g/day) M(24) 33 · 6 ± 7 · 5 M(19) 31 · 6 ± 7 · 7 1.5 (−0.08-3.1) Not significant
Quality: Control: Weight : Weight gain
(g/day)
F(31) 28 · 1 ± 5 · 8 F(24) 26 · 5 ± 4 · 9
Low risk of bias in all
parameters
Age: <10 days
Sample size: 70
Length: Length gain
(mm/month)
Length gain
(mm/month)
M(24) 35 ± 3 · 7 M(19) 37 · 3 ± 4 · 9 Not reported Not significant
Head circumference:
Change in head
circumference
(mm/month)
F(27) 32 · 8 ± 4 F(23) 32 ± 4 · 6
BMI: change in BMI per
month (kg/cm2/month)
Head circumference
(mm/month)
M(23) 18 ± 2 · 4 M(19) 17 · 5 ± 3 · 4 Not reported Not significant
F(29) 16 · 1 ± 2 · 7 F(24) 16 ± 3
BMI (kg/cm2/month) M(24) 1 · 1 ± 0 · 6 M(19) 1 ± 0 · 5 Not reported Not significant
F(27) 0 · 9 ± 0 · 5 F(23) 0 · 8 ± 0 · 4
ANOVA correcting
for sex
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Table 2 Effects of probiotics on child growth (Continued)
Zeigler et al. 2003 [34] Intervention: Outcome: Outcome Intervention
(RP + P)
Intervention
(RP)
Control Mean
difference
p-value
USA Age: 6–10 days Weight and Height Sample size 28 27 C:33
RCT Sample size: Units of measurement: Weight gain (g/day) 28.13 ± 4.63§ 29.3 ± 5.41§ 31.05 ± 5.88§ Not Reported 0.229
Quality: RP + P Weight: g/day
The risk of bias in adequate
sequence generation,
allocation concealment
and blinding was unclear
while there was a high risk
of bias in reporting of
incomplete outcome data
(Bifidobacterium lactis
in reduced protein
formula): 40
Length: mm/day M 13 32.1 ± 5.2 M 8 32.0 ± 4.7 M 19 32.2 ± 5.2
F 15 24.7 ± 4.9 F 19 28.2 ± 5.8 F 14 29.5 ± 6.9
RP (Reduced protein
formula): 40
Length gain (mm/day) M 13 1.14 ± 0.11 M 8 1.14 ± 0.09 M19 1.16 ± 0.09 Not reported 0.377
F 15 1.02 ± 0.07 F 19 1.06 ± 0.10 F14 1.07 ± 0.14
Control:
Age: 6–10 days
Sample size
Normal protein
formula: 42
Puccio et al. 2007 [31] Intervention: Outcomes: Outcome Intervention Control Mean difference
(90% CI)
p-value
Italy Age: <14 days Weight, height, head
circumference
Sample size 42 55
RCT Sample size: 65 Units of measurement: Weight (g/day) Not reported Not reported 0.50 (−1.48 ± 2.48) Not reported
Quality: Risk of bias was
unclear in both adequate
sequence generation and
allocation concealment
Control: Weight: weight gain (g/day) Height (mm/month) M 35.1 ± 4.2 M: 35 ± 4.4 Not reported 0.1
Age: <14 days Height: change in height
(mm/month)
F 32.2 ± 4.3 F : 32.2 ± 4.6 0.1
Sample size: 69 Head circumference: Change
in head circumference
(mm/month)
Head circumference
(mm/month)
M: 17.9 ± 2.7 M : 17.4 ± 2.9 Not reported >0.1 for all
F: 16.0 ± 2.8 F: 15.5 ± 3.0
Huet et al., 2006 [35] Intervention: Outcomes: Outcome Intervention Control Mean difference p-value
France Age: 1–28 days Weight, Height, Head
circumference
Sample size 117 86
CCT Sample size: 117 Units of measurement: Weight gain (g/day) 29.6 ± 6.6 29.8 ± 6.3 Not reported Not significant
Quality: The study had
high risk of bias in
adequate sequence
generation, allocation
concealment and blinding.
Control: Weight: weight gain (g/day) Height (cm/day) 0.110 ± 0.018 0.111 ± 0.018 Not reported Not significant
Age: 1-28 days Height: height gain (cm/day) Head circumference
(mm/day)
0.56 ± 0.12 0.55 ± 0.12 Not reported Not significant
Sample size: 86 Head circumference: change
in head circumference
(mm/day)
O
nubiet
al.Journalof
H
ealth,Population
and
N
utrition
 (2015) 34:8 
Page
9
of
15
Table 2 Effects of probiotics on child growth (Continued)
Gil-Campos et al. 2011 [27] Intervention: Outcomes: Outcome Intervention Control Mean difference p-value
Spain Age: 1 month Weight, Height, Head
Circumference
Sample size 61 60
RCT Sample size: 71 Units of measurement: Weight gain (g/day) 24.8 ± 5.1 25.3 ± 6.0 Not reported Not significant
Quality: There was low risk
of bias in all parameters.
Control: Weight: weight gain (g/day),
weight at 6 months (kg),
weight-for-age z-scores
at 6 months
Length gain (mm/day) 0.96 ± 0.3 0.90 ± 0.2 Not reported Not significant
Age: 1 month Length: Length gain
(mm/day), Length
at 6 months (cm), Length
for age z-scores at 6 months
Head Circumference
(mm/day)
0.43 ± 0.1 0.421 ± 0.1 Not reported Not significant
Weight at 6 months (kg) 8.0 ± 0.9 7.9 ± 1.0 Not reported Not significant
Sample size: 66 Head Circumference: Head
Circumference at 6 months
(cm), Head circumference
z-scores at 6 months
Length at 6 months (cm) 68.1 ± 3.4 66.6 ± 2.5 Not reported 0.038
Head Circumference at
6 months (cm)
43.7 ± 1.6 43.7 ± 1.3 Not reported Not significant
Weight for age z-scores
at 6 months
Not reported Not reported Not reported p = 0.061
Length for age z-scores
at 6 months
Not reported Not reported Not reported p = 0.021
Head circumference
z-scores at 6 months
Not reported Not reported Not reported p = 0.453
Section 2: In under-nourished
children
Author, year Sample details Outcomes and units of
measurement
Results
Country
Type of study
Quality
Nutritional status
Sazawal et al. 2010 [16] India Intervention: Outcomes: Outcome Intervention Control Mean difference p-value
RCT Age: 1–3 years Weight, height Sample size 257 245
Quality: The risk of bias
was low for all parameters
Sample size: 312 Units of measurement: Weight gain (g/year) 2,130 ± 590 2,000 ± 590 130 (30–230) 0.02
None severely malnourished Control: Weight: weight gain (g/year),
change in weight for age
z-score
Change in weight-for-
age z-score
0.34 ± 0.54 0.26 ± 0.54 0.08 (−0.02 to 0.17) 0.12
Nutritional status
Normal Age: 1–3 years Height (cm/year) 8.49 ± 1.41 8.28 ± 1.35 0.20 (−0.04 to 0.45) 0.09
I: 107 (34.3%) C: 95 (30.4%) Sample size: 312 Height: height gain (cm/year),
change in height for age
z-score after one year
change in height for
age z-score after 1 year
0.21 ± 0.42 0.18 ± 0.49 0.03 (−0.06 to 0.10) 0.55
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Wasted Difference in
weight/height
0.44 ± 0.65 0.34 ± 0.63 0.09 (−0.01 to 0.21) 0.09
I: 15 (4.8%) C: 14 (4.5%)
Stunted
I: 137 (43.9%) C: 157 (50.3%)
Wasted and stunted
I: 53 (17.0%) C: 46 (14.7%)
Saran et al., 2002 [13] Intervention: Outcomes: Outcome Intervention Control Mean difference p-value
India Age: 2–5 years Weight, height Sample size 50 50
Non-randomised controlled trial Sample size: 50 Units of measurement: Weight (g/6 months) 1,290 ± 730 810 ± 840 0.002 Not reported
Quality: high risk of bias for
adequate sequence
generation, allocation
concealment and blinding.
Control: Weight: weight gain
(g per 6 months)
Height: (cm/6months) 3.21 ± 1.48 1.74 ± 0.80 Not reported 0.0001
Nutritional status
Stunted (height for age)
and matched in both groups
Age: 2–5 years Height: height gain
(cm per 6 months)
Sample size: 50
He et al., 2005 [12] Intervention: Outcomes: Outcome Intervention Control Mean difference p-value
China Age: 3–5 years Weight, height Sample size 201 201
RCT Sample size: 201 Gram per 3, 6 and
9 months
700 ± 430 490 ± 350 Not reported 0.01
Quality: Control: Units of measurement:
Weight: Weight gain
(g per 3, 6 and 9 months),
Change in weight-for-age
at 3, 6 and 9 months
980 ± 620 800 ± 600 0.01
There was an unclear risk of
bias in adequate sequence
generation and high risk
of bias in both allocation
concealment and blinding
Age: 3–5 years 1,420 ± 760 1,200 ± 670 0.01
Sample size: 201 Change in weight-
for-age at 3, 6 and
9 months
0.139 ± 0.228 0.031 ± 0.184 0.01
Nutritional status
Undernourished - weight for
age and/or height for age
were below reference values
Height: change in height
for age z-scores at 9 months
0.058 ± 0.306 −0.047 ± 0.28 0.01
0.078 ± 0.365 −0.043 ± 0.28 0.01
Change in height for
age z-scores at 9 months
0.123 ± 0.168 0.077 ± 0.175 Not reported <0.01
Surono et al. 2011 [28]
Indonesia
Intervention: Outcomes: Weight Outcome Intervention Control Mean difference p-value
RCT Age: 15–54 months Units of measurement: Sample size 37 39
Sample size: 39 Weight: Mean gain in
bodyweight after 90 days
Mean bodyweight
gain (g)
1280 ± 940 990 ± 990 Not reported Not reported
O
nubiet
al.Journalof
H
ealth,Population
and
N
utrition
 (2015) 34:8 
Page
11
of
15
Table 2 Effects of probiotics on child growth (Continued)
Quality: Control:
There was an unclear risk
of bias in adequate sequence
generation, allocation
concealment and blinding.
Age: 15–54 monthss
Nutritional status
Underweight Sample size: 40
I: 20 C: 20
Severe Underweight
I: 7 C:10
Normal Bodyweight
I:10
C:9
No baseline differences between groups; Values presented in mean ± SD unless specified; NHCS: National Health Centre Statistics; MUAC: Mid Upper Arm Circumference.
§The results of weight gain per day for both sexes were combined and presented by the authors.
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most half were HIV positive and all the children were on
antibiotics. The lack of effects in the PRONUT study could
have been confounded by the fact that the children were
HIV positive, on antibiotics and acutely malnourished.
No evidence was found for a benefit of dietary intake
of probiotics on growth in well-nourished children in
developed countries. Some benefit was shown in terms
of weight gain in the one study in well-nourished chil-
dren in a developing country [29]. The benefit shown in
this study as compared to the others in well-nourished
children may be due to various factors including the
addition of prebiotics and LC-PUFA with the probiotics,
the age of the children and/or the developing country
setting. While some studies have shown there could be a
synergistic effect when combining pre- and probiotics
and a modulation of the immune system by combining
probiotics with LC-PUFA [7], other studies in this re-
view that also added either prebiotics or LC-PUFA did
not show any significant benefits in developed country
settings [30,31]. This indicates that the differences in
regimens are probably not responsible for the difference
in findings. The fact that this study was conducted on
an older group of children (12 months of age compared
to the other children who were less than 28 days at start
of study) might be another likely reason for the differ-
ences found. Findings in the review by the European
Society for Paediatric Gastroenterology, Hepatology and
Nutrition (ESPGHAN) indicate that probiotics adminis-
tered to children younger than four months of age do
not lead to any consistent clinical effects such as reduction
of gastro-intestinal infections unlike when given beyond
early infancy [39]. Most children in the other studies of
well-nourished children were younger than four months
old, which highlights the need for further research on
older children. Furthermore, the difference in benefits to
growth may be related to a number of factors peculiar to
developing country settings. It is worth noting that envir-
onmental factors such as the diet, eating practices and
sanitation may affect the efficacy of probiotics by modify-
ing the commensal gut flora [14], hence need to be taken
into consideration while advocating the use of probiotics
in different settings. Only one study was conducted among
well-nourished children in developing country making it
difficult to generalise the results for healthy children in
both developed and developing country settings. There-
fore, more research is needed particularly among healthy
children in developing countries for effective comparison.
In addition, only published studies were included in this
review which introduces bias and limiting the evidence.
Although this review did not aim to assess the benefits
of specific probiotic strains on diferent populations, it is
worth noting that Bifidobacterium lactis HN019; Bifdobac-
terium longum and Lactobacillus rhamnosus; lactobacillusacidophilus; thermophilus streptococci, bulgaria lactobacilli
and bifidum bacteria; and enterococcus faecium IS-27526
were all highlighted as beneficial strains in general by the
included studies. Different types of probiotics have distinct
effects and even those strains that are closely related may
have different clinical effects [7,8]. There is an emphasis by
the Food and Agricultural Organization (FAO) of the
United Nations that the effects of a specific strain should
not be assumed to occur in other strains [7]. More research
is needed on the specific strains that improve growth in
children in developing countries.
Probiotic containing food used in the studies in devel-
oping countries were from the local markets [12] or
locally prepared probiotics [13,28]. Given the benefits of
probiotics on child growth as hightlighted in this review,
use of readily available and less expensive fermented
food products as a vehicle of probiotics might play an
important role in improving nutrition, treating enteric
infections [40] and promoting compensatory growth in
children in developing countries through these different
mechanisms. However, more research is needed into the
consumer confidence, acceptability of fermented prod-
ucts as a source of probiotics and also the safety aspects
before promoting fermented foods in complementary
feeding in developing countries. Although the adminis-
tration of probiotics was not associated with serious ad-
verse effects from any of the studies included in this
review, it is recommended that probiotics be given to
critically ill or immuno-suppressed children with caution
as there have been rare cases of probiotic infections in
immuno-suppressed individuals and people with in-
dwelling catheters [8]. In spite of some probiotics studies
[38] showing no difference in probiotic related sepsis
among acutely malnourished and immunocompromised
children, the dearth of information on the safety issue of
probiotics in malnourished children should be considered
before promoting probiotics in this specific population.
What is already known and what this review adds
Previous reviews have shown the effectiveness of probio-
tics on growth in children with specific disease condi-
tions, whereas this is the first to report on the effects of
probiotics on measures of child growth in non clinical
settings. It is important to note that due to the paucity
of the number of studies that assessed the effects of
probiotics on child growth, all studies regardless of the
vehicle used in administering the probiotic were in-
cluded. Usually probiotics are added to infant formulas
in order to modify the micro-biota of babies who are
not breastfed to make it on par with breast-fed infants
[24,39], who benefit from certain lactic acid bacteria and
indigestible oligosaccharides which enhance the prolifer-
ation of probiotics [7,11]. Although a number of studies
using probiotic-enriched formula were included in this
Onubi et al. Journal of Health, Population and Nutrition  (2015) 34:8 Page 14 of 15review, the results by no means promote infant formula
fortified with probiotic as a substitute for breast milk, as
exclusive breastfeeding in the first six months is a key
child survival strategy [41,42]. This review showed that
probiotics improves growth in children and highlighted
that these benefits were more significiant in under-
nourished children and in a developing country setting
while highlighting no adverse effects on children
[27-29,32,33]. Given that under-nutrition is more preva-
lent in developing country settings [3], this review sug-
gests that probiotics may play an important role in
improving nutrition, promoting compensatory growth in
low resource countries. In addition, it also argues for the
idea of exploring the use of locally available and cultur-
ally acceptable fermented products as a vehicle of pro-
biotics, by investigating the safety and acceptability of
the products [40].
Conclusion and recommendations
This review found a benefit of dietary intake of probiotics
in terms of weight and height gain in under-nourished
children and possible benefit in terms of weight gain in
well-nourished children in developing countries. It is
suggested that the supplementation promotion of locally
available foods with probiotics could be an effective inter-
vention to improve growth in children, especially in devel-
oping countries. Further research is needed to investigate
this benefit among well-nourished children in a developing
country context especially in Africa where limited evidence
is available; under-nourished children in a developed coun-
try context, as well as in older children. Future studies on
probiotics should measure growth as a primary outcome
to strengthen the evidence and explore the acceptabilty of
the use of fermented milk products as a vehicle for
probiotics.
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